Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37,247
Closed -$26.9K 21
2025
Q1
$26.9K Hold
37,247
0.02% 34
2024
Q4
$44.3K Hold
37,247
0.04% 35
2024
Q3
$125K Hold
37,247
0.11% 36
2024
Q2
$203K Hold
37,247
0.22% 37
2024
Q1
$197K Hold
37,247
0.18% 40
2023
Q4
$233K Hold
37,247
0.15% 33
2023
Q3
$178K Hold
37,247
0.14% 33
2023
Q2
$223K Hold
37,247
0.14% 36
2023
Q1
$278K Hold
37,247
0.19% 36
2022
Q4
$462K Buy
37,247
+29,130
+359% +$511K 0.32% 32
2022
Q3
$167K Hold
8,117
0.11% 34
2022
Q2
$225K Hold
8,117
0.15% 34
2022
Q1
$355K Buy
+8,117
New +$353K 0.17% 33

Other funds holding AFMD

Nan Fung Group Holdings's AFMD Position: Q2 2025 in Review

Nan Fung Group Holdings sold out of Affimed (AFMD) in Q2 2025, closing a stake of 37,247 shares — an estimated $26.9K sold.

Nan Fung Group Holdings first reported a position in AFMD in Q1 2022 and held it in 13 quarters. The position peaked at $462K in Q4 2022. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.

  • Nan Fung Group Holdings reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
  • Nan Fung Group Holdings sold 37,247 Affimed shares in Q2 2025, an estimated $26.9K.
  • Nan Fung Group Holdings first reported a position in Affimed in Q1 2022 and held it in 13 quarters.
  • Nan Fung Group Holdings's Affimed position peaked at $462K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.

Based on Nan Fung Group Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.